These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 12552613

  • 1. Non-invasive imaging of vulnerable plaques by molecular targeting of oxidized LDL with tagged oxidation-specific antibodies.
    Tsimikas S, Shaw PX.
    J Cell Biochem Suppl; 2002; 39():138-46. PubMed ID: 12552613
    [Abstract] [Full Text] [Related]

  • 2. Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization.
    Torzewski M, Shaw PX, Han KR, Shortal B, Lackner KJ, Witztum JL, Palinski W, Tsimikas S.
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2307-12. PubMed ID: 15528482
    [Abstract] [Full Text] [Related]

  • 3. Noninvasive imaging of oxidized low-density lipoprotein in atherosclerotic plaques with tagged oxidation-specific antibodies.
    Tsimikas S.
    Am J Cardiol; 2002 Nov 21; 90(10C):22L-27L. PubMed ID: 12459423
    [Abstract] [Full Text] [Related]

  • 4. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
    Gounopoulos P, Merki E, Hansen LF, Choi SH, Tsimikas S.
    Minerva Cardioangiol; 2007 Dec 21; 55(6):821-37. PubMed ID: 18091649
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [New insights towards catheter-based identification of vulnerable plaque].
    Rodríguez-Granillo GA, Regar E, Schaar JA, Serruys PW.
    Rev Esp Cardiol; 2005 Oct 21; 58(10):1197-206. PubMed ID: 16238988
    [Abstract] [Full Text] [Related]

  • 7. Low level natural antibodies against phosphorylcholine: a novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease.
    Frostegård J.
    Clin Immunol; 2010 Jan 21; 134(1):47-54. PubMed ID: 19748321
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
    Matsuura E, Kobayashi K, Tabuchi M, Lopez LR.
    Prog Lipid Res; 2006 Nov 21; 45(6):466-86. PubMed ID: 16790279
    [Abstract] [Full Text] [Related]

  • 10. Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies.
    Hulthe J.
    Clin Chim Acta; 2004 Oct 21; 348(1-2):1-8. PubMed ID: 15369729
    [Abstract] [Full Text] [Related]

  • 11. Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods.
    Saia F, Schaar J, Regar E, Rodriguez G, De Feyter PJ, Mastik F, Marzocchi A, Marrozzini C, Ortolani P, Palmerini T, Branzi A, van der Steen AF, Serruys PW.
    J Cardiovasc Med (Hagerstown); 2006 Jan 21; 7(1):21-8. PubMed ID: 16645356
    [Abstract] [Full Text] [Related]

  • 12. [Identification of unstable coronary atherosclerotic plaques].
    Helft G, Worthley SG, Beygui F, Zaman AG, Le Feuvre C, Vacheron A, Metzger JP, Badimon JJ, Fuster V.
    Arch Mal Coeur Vaiss; 2001 Jun 21; 94(6):583-90. PubMed ID: 11480156
    [Abstract] [Full Text] [Related]

  • 13. From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report.
    Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, Fayad Z, Budoff MJ, Rumberger J, Naqvi TZ, Shaw LJ, Faergeman O, Cohn J, Bahr R, Koenig W, Demirovic J, Arking D, Herrera VL, Badimon J, Goldstein JA, Rudy Y, Airaksinen J, Schwartz RS, Riley WA, Mendes RA, Douglas P, Shah PK, SHAPE Task Force.
    Am J Cardiol; 2006 Jul 17; 98(2A):2H-15H. PubMed ID: 16843744
    [Abstract] [Full Text] [Related]

  • 14. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
    Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT.
    Circulation; 2003 Oct 14; 108(15):1772-8. PubMed ID: 14557340
    [Abstract] [Full Text] [Related]

  • 15. Molecular imaging of macrophage cell death for the assessment of plaque vulnerability.
    Laufer EM, Winkens MH, Narula J, Hofstra L.
    Arterioscler Thromb Vasc Biol; 2009 Jul 14; 29(7):1031-8. PubMed ID: 19461053
    [Abstract] [Full Text] [Related]

  • 16. The mainstream hypothesis that LDL cholesterol drives atherosclerosis may have been falsified by non-invasive imaging of coronary artery plaque burden and progression.
    Ware WR.
    Med Hypotheses; 2009 Oct 14; 73(4):596-600. PubMed ID: 19560285
    [Abstract] [Full Text] [Related]

  • 17. Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis.
    Peters MJ, van Halm VP, Nurmohamed MT, Damoiseaux J, Tervaert JW, Twisk JW, Dijkmans BA, Voskuyl AE.
    J Rheumatol; 2008 Aug 14; 35(8):1495-9. PubMed ID: 18597411
    [Abstract] [Full Text] [Related]

  • 18. Imaging of vulnerable coronary artery plaques.
    Hamdan A, Assali A, Fuchs S, Battler A, Kornowski R.
    Catheter Cardiovasc Interv; 2007 Jul 01; 70(1):65-74. PubMed ID: 17585387
    [Abstract] [Full Text] [Related]

  • 19. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
    Mayr M, Kiechl S, Tsimikas S, Miller E, Sheldon J, Willeit J, Witztum JL, Xu Q.
    J Am Coll Cardiol; 2006 Jun 20; 47(12):2436-43. PubMed ID: 16781371
    [Abstract] [Full Text] [Related]

  • 20. Colocalisation of intraplaque C reactive protein, complement, oxidised low density lipoprotein, and macrophages in stable and unstable angina and acute myocardial infarction.
    Meuwissen M, van der Wal AC, Niessen HW, Koch KT, de Winter RJ, van der Loos CM, Rittersma SZ, Chamuleau SA, Tijssen JG, Becker AE, Piek JJ.
    J Clin Pathol; 2006 Feb 20; 59(2):196-201. PubMed ID: 16443738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.